Yulang Jiang

Key Laboratory Of Liver And Kidney Diseases
Shuguang, 201203, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Alizarin as an NLRP3 inflammasome blocker ameliorates metabolic dysfunction-associated steatotic liver disease.

Alizarin as an NLRP3 inflammasome blocker ameliorates metabolic dysfunction-associated steatotic liver disease.

Journal: Journal of ethnopharmacology

Published: March 23, 2026

TRIM25-mediated ferroptosis resistance is closely associated with poor prognosis in hepatocellular carcinoma.

TRIM25-mediated ferroptosis resistance is closely associated with poor prognosis in hepatocellular carcinoma.

Journal: Frontiers in immunology

Published: January 21, 2026

The Achilles' heel of hepatocellular carcinoma: ginsenoside compound K as a novel GPX4 degrader promotes ferroptosis in hepatocellular carcinoma.

The Achilles' heel of hepatocellular carcinoma: ginsenoside compound K as a novel GPX4 degrader promotes ferroptosis in hepatocellular carcinoma.

Journal: Journal of translational medicine

Published: August 28, 2025

Gypenosides Ameliorate Hyperlipidemia by Activating Lipophagy through Modulation of the AMPK/mTOR/ULK1 Signaling Pathway.

Gypenosides Ameliorate Hyperlipidemia by Activating Lipophagy through Modulation of the AMPK/mTOR/ULK1 Signaling Pathway.

Journal: Journal of agricultural and food chemistry

Published: August 21, 2025

Weifuchun inhibits gastric cancer metastasis by inhibiting angiogenesis mediated by the miR-139-5p/CXCR4 axis.

Weifuchun inhibits gastric cancer metastasis by inhibiting angiogenesis mediated by the miR-139-5p/CXCR4 axis.

Journal: Journal of ethnopharmacology

Published: June 15, 2025

Synergistic Strategies in Systemic Therapy for Advanced Hepatocellular Carcinoma.

Synergistic Strategies in Systemic Therapy for Advanced Hepatocellular Carcinoma.

Journal: Global challenges (Hoboken, NJ)

Published: May 12, 2025

Exploring the mechanisms of WeifuChun in colorectal cancer: Network pharmacology-based identification and experimental validation of key signaling pathways.

Exploring the mechanisms of WeifuChun in colorectal cancer: Network pharmacology-based identification and experimental validation of key signaling pathways.

Journal: Journal of ethnopharmacology

Published: April 30, 2025

The mist of ferroptosis: The Orpheus journey of mitochondria - Exploring the symphony of cell fate.

The mist of ferroptosis: The Orpheus journey of mitochondria - Exploring the symphony of cell fate.

Journal: International journal of biological macromolecules

Published: April 26, 2025

ACSL4 at the helm of the lipid peroxidation ship: a deep-sea exploration towards ferroptosis.

ACSL4 at the helm of the lipid peroxidation ship: a deep-sea exploration towards ferroptosis.

Journal: Frontiers in pharmacology

Published: March 16, 2025

The renin-angiotensin-aldosterone system: An old tree sprouts new shoots.

The renin-angiotensin-aldosterone system: An old tree sprouts new shoots.

Journal: Cellular signalling

Published: June 30, 2024

Ginsenoside RK1 Induces Ferroptosis in Hepatocellular Carcinoma Cells through an FSP1-Dependent Pathway.

Ginsenoside RK1 Induces Ferroptosis in Hepatocellular Carcinoma Cells through an FSP1-Dependent Pathway.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 11, 2024

Integrated metabolomics and network pharmacology to explore the clinical efficacy and mechanism of Yinchenhao decoction combined with nucleoside analogues on chronic hepatitis B.

Integrated metabolomics and network pharmacology to explore the clinical efficacy and mechanism of Yinchenhao decoction combined with nucleoside analogues on chronic hepatitis B.

Journal: Journal of pharmaceutical and biomedical analysis

Published: June 06, 2024

Showing 1-12 of 20

Last Updated: 09/26/2026